DIRECT COMPARISON OF THE RELATIONSHIP BETWEEN CLINICAL OUTCOME AND CHANGE IN CD4(-POSITIVE HOMOSEXUAL MEN AND INJECTING DRUG-USERS() LYMPHOCYTES IN HUMAN IMMUNODEFICIENCY VIRUS)
Jb. Margolick et al., DIRECT COMPARISON OF THE RELATIONSHIP BETWEEN CLINICAL OUTCOME AND CHANGE IN CD4(-POSITIVE HOMOSEXUAL MEN AND INJECTING DRUG-USERS() LYMPHOCYTES IN HUMAN IMMUNODEFICIENCY VIRUS), Archives of internal medicine, 154(8), 1994, pp. 869-875
Background and Methods: To compare rates of decline of CD4(+) lymphocy
tes among human immunodeficiency virus-positivelymphocytes among human
immunodeficiency virus-positive homosexual men and injecting drug use
rs, we followed up prevalent human immunodeficiency virus-positive hom
osexual men and current or former injecting drug users from February 1
988 through August 1991. Subjects were free of acquired immunodeficien
cy syndrome at study entry and had semiannual clinical and laboratory
evaluation, including measurement of T-cell subsets, under common prot
ocols. Initial levels and rates of change of CD4(+) lymphocyte counts
were compared according to cohort membership and clinical progression,
defined by the development of thrush or an acquired immunodeficiency
syndrome-defining illness. Median follow-up was 30 months for both coh
orts. Results: At study entry, homosexual men had lower absolute numbe
rs of circulating CD4(-) lymphocytes than did injecting drug users (45
9/mu L [0.46X10(9)/L] vs 509/ mu L, respectively). During follow-up, h
omosexual men exhibited a faster decline in CD4(+) lymphocyte Counts a
s well as more frequent development of HIV-related symptoms (thrush or
acquired immunodeficiency syndrome). In both cohorts, initial levels
of CD4(+) lymphocytes and rates of decline in these cells were strongl
y associated with progression of disease, defined as remaining asympto
matic, onset of thrush, or onset of acquired immunodeficiency syndrome
. Once homosexual men and injecting drug users were stratified by dise
ase progression, their initial levels and rates of decline of CD4(+) l
ymphocyte counts were similar. Thus, crude differences between the two
study groups largely resulted from differences in development of clin
ical symptoms. Conclusions: In these cohorts of homosexual men and inj
ecting drug users, clinical outcome was much more important than risk
group membership in determining changes in CD4(+) lymphocyte numbers.
The close similarity between the groups also suggests that drug use, e
thnicity, and socioeconomic status play a minor role in the progressio
n of human immunodeficiency virus infection.